Origin matters: Differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones

Abstract

Calvarial bones arise from two embryonic tissues, namely, the neural crest and the mesoderm. In this study we have addressed the important question of whether disparate embryonic tissue origins impart variable osteogenic potential and regenerative capacity to calvarial bones, as well as what the underlying molecular mechanism(s). Thus, by performing in vitro and in vivo studies, we have investigated whether differences exist between neural crest–derived frontal and paraxial mesodermal–derived parietal bone. Of interest, our data indicate that calvarial bone osteoblasts of neural crest origin have superior potential for osteogenic differentiation. Furthermore, neural crest–derived frontal bone displays a superior capacity to undergo osseous healing compared with calvarial bone of paraxial mesoderm origin. Our study identified both in vitro and in vivo enhanced endogenous canonical Wnt signaling in frontal bone compared with parietal bone. In addition, we demonstrate that constitutive activation of canonical Wnt signaling in paraxial mesodermal–derived parietal osteoblasts mimics the osteogenic potential of frontal osteoblasts, whereas knockdown of canonical Wnt signaling dramatically impairs the greater osteogenic potential of neural crest–derived frontal osteoblasts. Moreover, fibroblast growth factor 2 (FGF-2) treatment induces phosphorylation of GSK-3β and increases the nuclear levels of β-catenin in osteoblasts, suggesting that enhanced activation of Wnt signaling might be mediated by FGF. Taken together, our data provide compelling evidence that indeed embryonic tissue origin makes a difference and that active canonical Wnt signaling plays a major role in contributing to the superior intrinsic osteogenic potential and tissue regeneration observed in neural crest–derived frontal bone. © 2010 American Society for Bone and Mineral Research

Shown for reading. Its publisher allows quoting it, not republishing it.

References 69

1. 1.

   Morriss-Kay GM. Derivation of the mammalian skull vault. J Anat. 2001;199:143-151.

   Not in our library10.1046/j.1469-7580.2001.19910143.x

2. 2.

   Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM. Tissue origins and interactions in the mammalian skull vault. Dev Biol. 2002;241:106-116.

   Not in our library10.1006/dbio.2001.0487

3. 3.

   Chai Y, Jiang X, Ito Y, et al. Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development. 2000;127:1671-1679.

   Not in our library10.1242/dev.127.8.1671

4. 4.

   LaBonne C, Bronner-Fraser M. Molecular mechanisms of neural crest formation. Annu Rev Cell Dev Biol. 1999;15:81-112.

   Not in our library10.1146/annurev.cellbio.15.1.81

5. 5.

   Anderson DJ. Genes, lineages and the neural crest: a speculative review. Philos Trans R Soc Lond B Biol Sci. 2000;355:953-964.

   Not in our library10.1098/rstb.2000.0631

6. 6.

   Trainor P, Krumlauf R. Development. Riding the crest of the Wnt signaling wave. Science. 2002;297:781-783.

   Not in our library10.1126/science.1075454

7. 7.

   Le Douarin NM, Calloni GW, Dupin E. The stem cells of the neural crest. Cell Cycle. 2008;7:1013-1019.

   Not in our library10.4161/cc.7.8.5641

8. 8.

   Couly G, Grapin-Botton A, Coltey P, Le Douarin NM. The regeneration of the cephalic neural crest, a problem revisited: the regenerating cells originate from the contralateral or from the anterior and posterior neural fold. Development. 1996;122:3393-3407.

   Not in our library10.1242/dev.122.11.3393

9. 9.

   Kontges G, Lumsden A. Rhombencephalic neural crest segmentation is preserved throughout craniofacial ontogeny. Development. 1996;122:3229-3242.

   Not in our library10.1242/dev.122.10.3229

10. 10.

    Karsenty G. Minireview: transcriptional control of osteoblast differentiation. Endocrinology. 2001;142:2731-2733.

    Not in our library10.1210/endo.142.7.8306

11. 11.

    Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2002;2:389-406.

    Not in our library10.1016/s1534-5807(02)00157-0

12. 12.

    Boulet AM, Moon AM, Arenkiel BR, Capecchi MR. The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth. Dev Biol. 2004;273:361-372.

    Not in our library10.1016/j.ydbio.2004.06.012

13. 13.

    Karsenty G. Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet. 2008;9:183-196.

    Not in our library10.1146/annurev.genom.9.081307.164437

14. 14.

    Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004;20:781-810.

    Not in our library10.1146/annurev.cellbio.20.010403.113126

15. 15.

    Nusse R. Wnt signaling in disease and in development. Cell Res. 2005;15:28-32.

    Not in our library10.1038/sj.cr.7290260

16. 16.

    Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469-480.

    Not in our library10.1016/j.cell.2006.10.018

17. 17.

    Hartmann C. A Wnt canon orchestrating osteoblastogenesis. Trends Cell Biol. 2006;16:151-158.

    Not in our library10.1016/j.tcb.2006.01.001

18. 18.

    Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202-1209.

    Not in our library10.1172/jci28551

19. 19.

    Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science. 2004;303:1483-1487.

    Not in our library10.1126/science.1094291

20. 20.

    Moon RT, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science. 2002;296:1644-1646.

    Not in our library10.1126/science.1071549

21. 21.

    Lee JS, Ishimoto A, Yanagawa S. Characterization of mouse dishevelled (Dvl) proteins in Wnt/Wingless signaling pathway. J Biol Chem. 1999;274:21464-21470.

    Not in our library10.1074/jbc.274.30.21464

22. 22.

    Seto ES, Bellen HJ. The ins and outs of Wingless signaling. Trends Cell Biol. 2004;14:45-53.

    Not in our library10.1016/j.tcb.2003.11.004

23. 23.

    Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 1998;17:1371-1384.

    Not in our library10.1093/emboj/17.5.1371

24. 24.

    Akiyama T. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 2000;11:273-282.

    Not in our library10.1016/s1359-6101(00)00011-3

25. 25.

    He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509-1512.

    Not in our library10.1126/science.281.5382.1509

26. 26.

    Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426.

    Not in our library10.1038/18884

27. 27.

    Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/β-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22:1172-1183.

    Not in our library10.1128/mcb.22.4.1172-1183.2002

28. 28.

    Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell. 2005;8:727-738.

    Not in our library10.1016/j.devcel.2005.02.013

29. 29.

    Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell. 2005;8:739-750.

    Not in our library10.1016/j.devcel.2005.03.016

30. 30.

    Gong Y, Slee RB, Fukai N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001;107:513-523.

    Not in our library10.1016/s0092-8674(01)00571-2

31. 31.

    Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene. 2004;341:19-39.

    Not in our library10.1016/j.gene.2004.06.044

32. 32.

    Glass DA, Bialek P, Ahn JD, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005;8:751-764.

    Not in our library10.1016/j.devcel.2005.02.017

33. 33.

    Boyden LM, Mao J, Belsky J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002;346:1513-1521.

    Not in our library10.1056/nejmoa013444

34. 34.

    Babij P, Zhao W, Small C, et al. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res. 2003;18:960-974.

    Not in our library10.1359/jbmr.2003.18.6.960

35. 35.

    Little RD, Carulli JP, Del Mastro RG, et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002;70:11-19.

    Not in our library10.1086/338450

36. 36.

    Holmen SL, Giambernardi TA, Zylstra CR, et al. Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6. J Bone Miner Res. 2004;19:2033-2040.

    Not in our library10.1359/jbmr.040907

37. 37.

    Kato M, Patel MS, Levasseur R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol. 2002;157:303-314.

    Not in our library10.1083/jcb.200201089

38. 38.

    Chung BD, Kayserili H, Ai M, et al. A mutation in the signal sequence of LRP5 in a family with an osteoporosis-pseudoglioma syndrome (OPPG)-like phenotype indicates a novel disease mechanism for trinucleotide repeats. Hum Mutat. 2009.

    Not in our library10.1002/humu.20916

39. 39.

    Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes Dev. 1994;8:174-189.

    Not in our library10.1101/gad.8.2.174

40. 40.

    Ikeya M, Takada S. Wnt-3a is required for somite specification along the anteroposterior axis of the mouse embryo and for regulation of cdx-1 expression. Mech Dev. 2001;103:27-33.

    Not in our library10.1016/s0925-4773(01)00338-0

41. 41.

    Galceran J, Farinas I, Depew MJ, Clevers H, Grosschedl R. Wnt3a–/–-like phenotype and limb deficiency in Lef1–/–Tcf1–/– mice. Genes Dev. 1999;13:709-717.

    Not in our library10.1101/gad.13.6.709

42. 42.

    Quarto NWD, Longaker MT. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone. 2008.

    Not in our library10.1016/j.bone.2008.01.026

43. 43.

    Kolligs FT, Hu G, Dang CV, Fearon ER. Neoplastic transformation of RK3E by mutant β-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression. Mol Cell Biol. 1999;19:5696-5706.

    Not in our library10.1128/mcb.19.8.5696

44. 44.

    Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng. 2006;12:1405-1418.

    Not in our library10.1089/ten.2006.12.1405

45. 45.

    Quarto N, Fong KD, Longaker MT. Gene profiling of cells expressing different FGF-2 forms. Gene. 2005;356:49-68.

    Not in our library10.1016/j.gene.2005.05.014

46. 46.

    Wan DC, Shi YY, Nacamuli RP, Quarto N, Lyons KM, Longaker MT. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci USA. 2006;103:12335-12340.

    Not in our library10.1073/pnas.0604849103

47. 47.

    Quarto N, Finger FP, Rifkin DB. The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal. J Cell Physiol. 1991;147:311-318.

    Not in our library10.1002/jcp.1041470217

48. 48.

    Quarto N, Behr B, Li S, Longaker MT. Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs. 2009.

    Not in our library10.1159/000202789

49. 49.

    Yu HM, Jerchow B, Sheu TJ, et al. The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development. 2005;132:1995-2005.

    Not in our library10.1242/dev.01786

50. 50.

    Chen Y, Alman BA. Wnt pathway, an essential role in bone regeneration. J Cell Biochem. 2009;106:353-362.

    Not in our library10.1002/jcb.22020

51. 51.

    Macsai CE, Foster BK, Xian CJ. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J Cell Physiol. 2008;215:578-587.

    Not in our library10.1002/jcp.21342

52. 52.

    Leucht P, Minear S, Ten Berge D, Nusse R, Helms JA. Translating insights from development into regenerative medicine: the function of Wnts in bone biology. Semin Cell Dev Biol. 2008;19:434-443.

    Not in our library10.1016/j.semcdb.2008.09.002

53. 53.

    Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 1997;11:3286-3305.

    Not in our library10.1101/gad.11.24.3286

54. 54.

    Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, et al. Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation. Oncogene. 2001;20:252-259.

    Not in our library10.1038/sj.onc.1204064

55. 55.

    Israsena N, Hu M, Fu W, Kan L, Kessler JA. The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells. Dev Biol. 2004;268:220-231.

    Not in our library10.1016/j.ydbio.2003.12.024

56. 56.

    Holnthoner W, Pillinger M, Groger M, et al. Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells. J Biol Chem. 2002;277:45847-45853.

    Not in our library10.1074/jbc.m209354200

57. 57.

    Shimizu T, Kagawa T, Inoue T, et al. Stabilized β-catenin functions through TCF/LEF proteins and the Notch/RBP-Jκ complex to promote proliferation and suppress differentiation of neural precursor cells. Mol Cell Biol. 2008;28:7427-7441.

    Not in our library10.1128/mcb.01962-07

58. 58.

    Gaur T, Lengner CJ, Hovhannisyan H, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005;280:33132-33140.

    Not in our library10.1074/jbc.m500608200

59. 59.

    Kim JB, Leucht P, Lam K, et al. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res. 2007;22:1913-1923.

    Not in our library10.1359/jbmr.070802

60. 60.

    Kitagaki J, Iwamoto M, Liu JG, Tamamura Y, Pacifci M, Enomoto-Iwamoto M. Activation of β-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. Osteoarthritis Cartilage. 2003;11:36-43.

    Not in our library10.1053/joca.2002.0863

61. 61.

    Leucht P, Kim JB, Helms JA. β-Catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg Am. 2008;90(Suppl 1):3-8.

    Not in our library10.2106/jbjs.g.01136

62. 62.
    Beta-Catenin Signaling Plays a Disparate Role in Different Phases of Fracture Repair: Implications for Therapy to Improve Bone Healing · 2007

    No notice
63. 63.

    Leucht P, Kim JB, Amasha R, James AW, Girod S, Helms JA. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development. 2008;135:2845-2854.

    Not in our library10.1242/dev.023788

64. 64.

    Wei K, Chen J, Akrami K, Galbraith GC, Lopez IA, Chen F. Neural crest cell deficiency of c-myc causes skull and hearing defects. Genesis. 2007;45:382-390.

    Not in our library10.1002/dvg.20304

65. 65.

    Fischer L, Boland G, Tuan RS. Wnt signaling during BMP-2 stimulation of mesenchymal chondrogenesis. J Cell Biochem. 2002;84:816-831.

    Not in our library10.1002/jcb.10091

66. 66.

    McManus EJ, Sakamoto K, Armit LJ, et al. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knock-in analysis. EMBO J. 2005;24:1571-1583.

    Not in our library10.1038/sj.emboj.7600633

67. 67.

    Reinhold MI, Naski MC. Direct interactions of Runx2 and canonical Wnt signaling induce FGF-18. J Biol Chem. 2007;282:3653-3663.

    Not in our library10.1074/jbc.m608995200

68. 68.

    Kratochwil K, Galceran J, Tontsch S, Roth W, Grosschedl R. FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1–/– mice. Genes Dev. 2002;16:3173-3185.

    Not in our library10.1101/gad.1035602

69. 69.

    ten Berge D, Brugmann SA, Helms JA, Nusse R. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development. 2008;135:3247-3257.

    Not in our library10.1242/dev.023176

Cited by papers we hold 4

• Regulation and Role of Transcription Factors in Osteogenesis · 2021
  No notice
• Making and shaping endochondral and intramembranous bones · 2020
  No notice
• Functional Relationship between Osteogenesis and Angiogenesis in Tissue Regeneration · 2020
  No notice
• Animal models for bone tissue engineering and modelling disease · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.